Table 3.

Interventional trials recruiting subjects with steroid-refractory acute GVHD*

NCT numberAgentPhaseRandomizedSponsor type
NCT02525029 Chorionic gonadotropin 1-2 No Academic 
NCT03819803 Fecal microbiota transplantation No Academic 
NCT03359980 Fecal microbiota transplantation No Industry 
NCT03631589 Mesenchymal stem cells 2-3 No Academic 
NCT03158896 Mesenchymal stem cells No Academic 
NCT02687646 Mesenchymal stem cells 1-2 No Public 
NCT00603330 Mesenchymal stem cells No Academic 
NCT03327857 Neihulizumab No Industry 
NCT03491215 Ruxolitinib 1-2* No Industry 
NCT02396628 Ruxolitinib Yes Academic 
NCT numberAgentPhaseRandomizedSponsor type
NCT02525029 Chorionic gonadotropin 1-2 No Academic 
NCT03819803 Fecal microbiota transplantation No Academic 
NCT03359980 Fecal microbiota transplantation No Industry 
NCT03631589 Mesenchymal stem cells 2-3 No Academic 
NCT03158896 Mesenchymal stem cells No Academic 
NCT02687646 Mesenchymal stem cells 1-2 No Public 
NCT00603330 Mesenchymal stem cells No Academic 
NCT03327857 Neihulizumab No Industry 
NCT03491215 Ruxolitinib 1-2* No Industry 
NCT02396628 Ruxolitinib Yes Academic 

Data are from ClinicalTrials.gov, accessed 15 July 2019.

*

Pediatric.

or Create an Account

Close Modal
Close Modal